Internal Medicine, Gastroenterology · North Chesterfield, VA
NPI
1982812681
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
169 Wadsworth Dr
North Chesterfield, VA, 23236
Phone (804) 330-4201
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
1,477 services
Medicare patients, 2024
870
Average age 73
Drug cost, 2024
$1.2M
2,804 prescriptions
Company payments, 2025
$1,312
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Flynn was code 99214 (office e&m - established), 293 times for 230 patients. In total Robert Flynn billed 1,477 services in 48 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 293 | 230 | $95.93 | $28K |
| 45385 Colonoscopy - Lesion Removal | Facility | 208 | 207 | $213.27 | $44K |
| 99232 Hospital E&M - Subsequent | Facility | 153 | 98 | $64.29 | $9,837 |
| 43239 Upper GI Endoscopy | Facility | 134 | 132 | $67.64 | $9,064 |
| 45380 Lower GI Endoscopy - Other | Facility | 127 | 127 | $100.67 | $13K |
| 99222 Hospital E&M - Initial | Facility | 78 | 77 | $99.54 | $7,764 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 70 | 69 | $181.42 | $13K |
| 99204 Office E&M - New | Office | 68 | 68 | $120.49 | $8,194 |
| 99213 Office E&M - Established | Office | 63 | 61 | $59.65 | $3,758 |
| 43235 Upper GI Endoscopy | Facility | 44 | 44 | $70.50 | $3,102 |
| 43249 Upper GI Endoscopy | Facility | 40 | 40 | $105.52 | $4,221 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 37 | 37 | $178.70 | $6,612 |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 26 | 24 | $47.67 | $1,239 |
| 99203 Office E&M - New | Office | 21 | 21 | $76.80 | $1,613 |
| 45378 Lower GI Endoscopy - Other | Facility | 16 | 16 | $142.61 | $2,282 |
By year: 2022 $153K for 1,481 services; 2023 $154K for 1,475 services; 2024 $166K for 1,477 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert Flynn prescribed most often to Medicare patients was Pantoprazole Sodium, with 451 prescriptions and refills. In total Robert Flynn wrote 2,804 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 451 | 999 | 117 | $10K |
| Omeprazole Generic | 283 | 716 | 88 | $3,176 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 217 | 217 | 212 | $2,984 |
| Famotidine Generic | 153 | 290 | 25 | $3,817 |
| Esomeprazole Magnesium Generic | 147 | 304 | 34 | $6,478 |
| Linzess Linaclotide | 96 | 132 | 16 | $70K |
| Dicyclomine Hcl Generic | 86 | 148 | 37 | $1,339 |
| Dexlansoprazole Dr Dexlansoprazole | 83 | 181 | 19 | $27K |
| Cholestyramine Cholestyramine (With Sugar) | 78 | 111 | 17 | $4,489 |
| Creon Lipase/Protease/Amylase | 76 | 108 | 18 | $131K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 59 | 59 | 59 | $810 |
| Sucralfate Generic | 57 | 74 | 19 | $2,474 |
| Mesalamine Er Mesalamine | 56 | 110 | 13 | $11K |
| Mesalamine Generic | 48 | 119 | 13 | $40K |
| Promethazine Hcl Generic | 47 | 47 | Under 11 | $196 |
Brand drugs: - claims; generic drugs: 2,298 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert Flynn $1,312 ($1,312 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $591.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $591 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $149 |
| Genzyme Corporation SNY | 5 | $149 |
| Pfizer Inc. PFE | 3 | $63.4 |
| Lilly USA, LLC LLY | 2 | $48.53 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $48.43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $38.34 |
| Madrigal Pharmaceuticals MDGL | 2 | $37.65 |
| Ardelyx, Inc. ARDX | 2 | $29.56 |
| Gilead Sciences, Inc. GILD | 1 | $28.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.